The Processvalethealth2024-03-25T03:04:10+00:00

The PearlPAK™ Process

The CleopatraRX™ team is ready to facilitate your connection with a medical practitioner and pharmacy to prescribe a PearlPAK™* treatment plan tailored to fit your needs.

The PearlPAK™ Process

The CleopatraRX™ team is ready to facilitate your connection with a medical practitioner and pharmacy to prescribe a PearlPAK™ treatment plan tailored to fit your needs.

Begin your journey to better brain health today and prevent brain fog during menopause with PearlPAK™.

Step 1: Qualification

STEP 1: QUALIFICATION

Step 1: Qualification

Begin with the online questionnaire to determine if PearlPAK™ is right for you.

After a review with the Registered Nurse, your file is further evaluated by the telehealth medical practitioner.

Step 2: Appointment

STEP 2: APPOINTMENT

Step 2: Appointment

Within the first 30 minutes, the medical practitioner will connect with you via text or email to schedule a telemedicine consultation to determine the next steps.

During the call, the practitioner will evaluate if PearlPAK™ is a good fit for you, and if you choose, they will write a tailored PearlPAK™ prescription for you.

Step 3: Prescription Delivered

STEP 3: PRESCRIPTION DELIVERED

Step 3: Prescription Delivered

The PearlPAK™ prescription is sent to our pharmacy partner and the medication delivered directly to your door.

Within 7 business days, a 3-month dose of PearlPAK™ arrives at your door with all the information you need to begin treatment.

Step 4: Follow Up

STEP 4: FOLLOW-UP

Step 4: Follow Up

Before completion of the first 3-month dose, you will receive a follow-up survey to check in and see how you are feeling and to aid the medical practitioner in determining if the dosage amount should be adjusted or remain the same.

Step 5: Refill Prescription

STEP 5: REFILL PRESCRIPTION

Step 5: Refill Prescription

After the follow-up questionnaire, the medical practitioner will send the appropriate refill prescription to our pharmacy partner for another 3-month dose.

The refill is delivered to your front door to continue the treatment.

Interested in more information?

Learn how it works

Download the complete process.

© Copyright 2024 CleopatraRX™. All Rights Reserved. View our Privacy Policy.

*PearlPAK™️ dose system is not intended to treat neurological diseases including dementia and Alzheimer’s Disease. It is specifically designed to target cognitive difficulties in perimenopause and early menopausal women only. If you are concerned about neurological disease or have a family history of neurological disease, contact your physician.

CleopatraRX™ and PearlPAK™ are trademarks of CleopatraRX Development, LLC. CleopatraRX™ is a service mark and is used throughout this website to represent the services offered by CleopatraRX Development, LLC. PearlPAK™ is a dosage product for use as a drug/routine system and/or treatment.

The PearlPAK™️ drug/routine system is protected by U.S. Patent No. 10,369,158 – PHARMACEUTICAL PACKAGING FOR ESTRIOL THERAPY – which relates to novel packaged pharmaceutical products for the treatment of neurodegenerative diseases, such as multiple sclerosis, and methods of using these products.

Estriol Therapy U.S. Patent No. 9,962,395 – COMPOSITIONS AND METHODS FOR MAINTAINING COGNITIVE FUNCTION – Provides methods for reducing the progression of cognitive decline in a post-menopausal woman using a continuous regimen of estrogen in combination with periodic administration of a progestogen.

*PearlPAK™ dose system is not intended to treat neurological diseases including dementia and Alzheimer’s Disease. It is specifically designed to target cognitive difficulties in perimenopause and early menopausal women only. If you are concerned about neurological disease or have a family history of neurological disease, contact your physician.

CleopatraRX™ and PearlPAK™ are trademarks of CleopatraRX Development, LLC. CleopatraRX™ is a service mark and used throughout this website to represent the services offered by CleopatraRX Development, LLC. PearlPAK™ is a dosage product is for use as a drug/routine system and/or treatment.

The PearlPAK™ drug/routine system is protected by U.S. Patent No. 10,369,158 – PHARMACEUTICAL PACKAGING FOR ESTRIOL THERAPY – which relates to novel packaged pharmaceutical products for the treatment of neurodegenerative diseases, such as multiple sclerosis, and methods of using these products.

Estriol Therapy U.S. Patent No. 9,962,395 – COMPOSITIONS AND METHODS FOR MAINTAINING COGNITIVE FUNCTION – Provides methods for reducing the progression of cognitive decline in a post – menopausal woman using a continuous regimen of estrogen in combination with periodic administration of a progestogen.